Glutamatergic excitation suppresses latent cortical pacemaking
Related Experiment Video
Updated: Nov 7, 2026

Generation of Local CA1 γ Oscillations by Tetanic Stimulation
Published on: August 14, 2015
Abstract:
Glutamate provides the principal excitatory drive in the cortex, so reducing ionotropic glutamatergic transmission is expected to suppress neuronal activity. We asked whether reducing ongoing glutamatergic excitation can reveal a previously unrecognized form of neuronal activity: a local population timing mechanism. Combining two established single-neuron constraints (near-threshold susceptibility and spike-history-dependent loss of excitability) we proposed an availability reservoir: a local population can generate a burst only when enough neurons are both susceptible and recovered. This hypothesis predicted a counterintuitive result: local glutamate-receptor antagonism should not simply silence the awake cortex, but should allow the eligible pool to refill and reveal recurrent burst-quiescence. In the awake rabbit cortex, local glutamate-receptor antagonism produced stereotyped local-field-potential and multi-unit population bursts separated by quiescence. Increasing GABAergic inhibition progressively reduced burst size and recurrence before abolishing the pacemaker regime, whereas reducing GABAergic inhibition under baseline conditions produced epileptiform activity with different timing and intra-burst structure. Thus, glutamatergic excitation can mask a recovery-dependent cortical population pacemaker regime. The same framework distinguishes recovery-dependent burst-quiescence from disinhibited epileptiform bursting, providing an operational separation between visually similar but mechanistically different brain states.
Related Concept Videos
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Antiepileptic Drugs: Glutamate Antagonists
Long-term Potentiation
Hebbian LTP
LTP can occur when presynaptic neurons...
Long-term Potentiation
Integration of Synaptic Events
Excitatory and Inhibitory Effects of Neurotransmitters

